Fig. 4: Inflammatory response and invagination of the UroLift implant following treatment.
From: The UroLift implant: mechanism behind rapid and durable relief from prostatic obstruction
A Cystoscopic images of apex at baseline, (B) at 12 months post treatment and (C) at 27 months post treatment show absence of inflammation at 12 and 27 months post implantation. Arrow indicates invaginated tissue where an implant had been placed. The urethra in that area shows no difference from the healthy urethra on the contralateral side.
